NYU Langone Health is partnering with Isaac Health to launch a specialist-led virtual care model aimed at reducing long waits for memory care. The partnership will test whether telehealth can expand access without sacrificing quality as demand for neurologists continues to outpace supply.
The solution isn't about creating more referral pathways, but about building the measurement infrastructure that enables excellent primary care providers to act confidently on their observations.
How can AI benefit and improve patient outcome in the emergency department? Watch the latest episode to find out.
NewDays' $7 million seed round was led by General Catalyst and Madrona. The funds will be used to expand into additional states and grow its team.
Mount Sinai researchers published a study that could improve neuroscientists’ understanding of the progression of Alzheimer’s and other forms of cognitive decline. It proved that white matter may be a more important region to look at than was previously thought.
uMETHOD, which provides precision medicine software to treat cognitive decline, tapped at-home diagnostics provider Getlabs to supply mobile phlebotomies for its patients in Arizona. Blood tests are an essential part of the personalized care plans that uMETHOD provides, and the partnership seeks to make these tests accessible to patients with cognitive decline.
Early results from a study conducted by Evidation Health, Eli Lilly and Apple have shown the ability to detect cognitive decline and mild Alzheimer’s disease using a combination of Apple wearables, mobile devices, digital apps and sleep sensors.
Greenway Health blends smart technology with human expertise to elevate revenue cycle.
The company's platform consists of a digital assessment to measure memory health and an associated program meant to drive better healthy behaviors and training exercises as a way to improve cognitive health.